On Tuesday, Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN)’s shares inclined 3.63% to $8.86.
Achillion Pharmaceuticals, Inc. (ACHN) the Company’s stockholders approved the Company’s 2015 Stock Incentive Plan (the “2015 Plan”). The 2015 Plan replaced the Company’s 2006 Stock Incentive Plan, as amended (the “2006 Plan”). Upon the approval of the 2015 Plan by stockholders, the 2006 Plan terminated, and all then outstanding awards under the 2006 Plan will remain in effect, but no additional awards will be made under the 2006 Plan. However, the terms of the 2006 Plan will continue to apply to awards formerly granted under the 2006 Plan.
The 2015 Plan allows for the issuance of 6,900,000 new shares of common stock plus up to 1,894,444 shares of common stock that remained accessible for issuance under the formerly approved 2006 Plan right away prior to the effectiveness of the 2015 Plan, all of which shares rolled over and became accessible for issuance under the 2015 Plan upon its effectiveness. Solely to the extent that any of the 8,726,686 shares of common stock subject to awards that were issued and outstanding under the 2006 Plan right away prior to the effectiveness of the 2015 Plan expire, terminate, are surrendered, cancelled or forfeited, such shares also will become accessible for the future grant of awards under the 2015 Plan. All of the foregoing share numbers are subject, in the case of incentive stock options, to any limitations under the Internal Revenue Code of 1986, as amended (the “Code”), and are also subject to adjustment upon stock splits, stock dividends, and other specified events. Certain sub-limitations apply to the shares accessible for issuance under the 2015 Plan. The 2015 Plan allows for the issuance of incentive stock options intended to qualify under Section 422 of the Code, nonstatutory stock options, stock appreciation rights, restricted stock awards, restricted stock units and other stock-based awards. The maximum number of shares with respect to which awards may be granted to any participant under the 2015 Plan may not exceed 1,500,000 shares per fiscal year (subject to adjustment upon stock splits, stock dividends, and other specified events). The maximum aggregate number of shares with respect to which awards may be granted to directors who are not employees of the Company at the time of grant will be 10% of the maximum number of shares authorized for issuance under the 2015 Plan.
The material terms of the 2015 Plan are summarized on pages 18 through 27 of the Company’s definitive proxy statement on Plan 14A filed with the Securities and Exchange Commission (the “SEC”) on April 17, 2015, which description is attached hereto as exhibit 99.1 and incorporated herein by reference. The description of the 2015 Plan is qualified in its entirety by reference to the full text of the 2015 Plan, a copy of which is attached hereto as Exhibit 10.1 and is incorporated herein by reference.
Achillion Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes anti-infective drug therapies in the United States and internationally. It focuses on developing combination therapies for the treatment of chronic hepatitis C (HCV) infection and drug-resistant bacterial infections
TD Ameritrade Holding Corp. (NYSE:AMTD)’s shares gained 0.25% to $36.82.
TD Ameritrade Holding Corporation (AMTD) declared company metrics for May 2015.
Monthly activities for May 2015 comprised of:
- An average of 427,000 client trades per day in May 2015, up 11 percent from May 2014 and down 7 percent from April 2015.
- $710.8 billion in total client assets as of May 31, 2015, up 12 percent from May 2014 and up 1 percent from April 2015.
- Average spread-based balances(1)of $95.1 billion, up 4 percent from May 2014 and essentially flat from April 2015.
- Average fee-based balances(1)of $161.8 billion, up 17 percent from May 2014 and up 1 percent from April 2015.
TD Ameritrade Holding Corporation provides securities brokerage services and related technology-based financial services to retail investors, traders, and independent registered investment advisors (RIAs) in the United States. Its products and services comprise tdameritrade.com, a Web platform for self-directed retail investors; Trade Architect, a Web-based platform that enables active investors and traders identify opportunities and stay informed; thinkorswim, a desktop platform for trading; and TD Ameritrade Mobile, which allows on-the-go investors and traders to trade and monitor accounts from Web-enabled mobile devices.
At the end of Tuesday’s trade, SUPERVALU INC. (NYSE:SVU)‘s shares dipped -1.46% to $8.09.
Supervalu Inc.(SVU) paid Sam Duncan, its president and CEO, 40 percent more in fiscal 2015 than it did in the previous year, boosting his total compensation to $6.92 million, up from $4.95 million in 2014.
Duncan, 63, has been CEO and president of the grocery wholesaler and retailer since February 2013, when he took over for Wayne Sales, who had been CEO for just seven months. Sales remains a member of Supervalu’s board of directors. The CEO turnover at Supervalu drew a lot of attention to the company’s high compensation for executives and directors.
Duncan’s jump in pay this year was mainly a result of a large stock award he received for the company’s continued positive turnaround, which comprises improved same-store-sales, adjusted earnings and shareholder returns, among others metrics, according to the company’s proxy. Supervalu’s total market capitalization grew from $1.59 billion at the end of fiscal 2014 to $2.59 billion at the end of fiscal 2015.
Former Target Corp. executive Gerald Storch has been nominated by the Supervalu board to continue as non-executive chairman, a position he’s held since January 2014. Since this January, Storch also has been CEO of Hudson’s Bay Co., a retail business group based in Brampton, Ontario.
SUPERVALU INC., together with its auxiliaries, operates as a grocery wholesaler and retailer in the United States. The company operates through three segments: Independent Business, Save-A-Lot, and Retail Food. The Independent Business segment offers wholesale distribution of various food and non-food products to independent retail customers, such as single and multiple grocery store independent operators, regional chains, and the military. As of February 28, 2015, this segment operated about 1,825 stores with a network spanning 41 states.
Amazon.com, Inc. (NASDAQ:AMZN), ended its Tuesday’s trading session with 0.98% gain, and closed at $434.09.
Amazon (AMZN) declared the Selling on Amazon and Fulfillment by Amazon offerings in Mexico for businesses of all sizes to list and sell their products at Amazon.com.mx. In 2014, sellers worldwide on Amazon set a new record by selling more than 2 billion items. Recently, more than 40 percent of Amazon’s total unit sales come from third-party selection.
Customers flock to Amazon because of the vast selection of items across a diverse set of categories, at low prices. At launch, Amazon.com.mx has the largest selection of items in Mexico, with millions of unique items accessible to customers for local delivery. Mexican customers searching for local or imported items will be able to browse and purchase products accessible from Mexican businesses and online sellers
Amazon.com, Inc. operates as an online retailer in North America and internationally. It operates in two segments, North America and International. The company serves consumers through retail Websites, such as amazon.com and amazon.ca, which primarily comprise merchandise and content purchased for resale from vendors and those offered by third-party sellers.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
